Delivery Order SPE2DB20D1109-SPE2DB24FP53Z

Award Date 7/19/24
Potential Completion Date 7/22/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4,567,706,514 units of methylphenidate extended-release 20mg capsules, with a ceiling value of $1,483.93. The contract is a firm fixed-price delivery order with a period of performance through March 27, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $1,078.09 firm-fixed-price contract is for the supply of 4565229014 - Methylphenidate ER (Long-Acting) 20mg capsules. The contract has a completion date of July 24, 2024 and was awarded on July 23, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to...
This is a $1,434.59 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides for the delivery of 100 units of Methylphenidate ER (long-acting) 30mg capsules, with a period of performance through June 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) vehicle held by AmerisourceBergen with DLA Troop Support...
This is a $1,135.20 firm-fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply 4,565,404,218 units of 27 mg methylphenidate extended-release tablets. The order has an ultimate completion date of August 12, 2024. AmerisourceBergen is the prime contractor for this award, which is not set-aside. The order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,558.85, is for the delivery of 4,562,801,874 units of Methylphenidate LA 20 mg capsules. The contract has an ultimate completion date of November 14, 2023 and is a firm fixed-price delivery order. This contract is part of a larger Indefinite Delivery Contract (IDC) that...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,107,646 units of the medication Methylphenidate ER (extended-release) 20mg capsules, with a ceiling value of $1,190.84. The contract is a firm fixed-price, non-set-aside arrangement with a performance period through May 2, 2025. AmerisourceBergen Drug Corp holds a...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,170.09 firm fixed-price contract is for the supply of 4,563,289,730 units of Methylphenidate ER 18 mg tablets. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for $1,336.44 to supply 4,565,890,480 tablets of 18 mg methylphenidate extended-release. The contract is a firm fixed-price delivery order with a completion date of September 23, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies to provide a wide range of essential medical products and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,413.32 firm fixed price contract is for the delivery of 60mg methylphenidate extended-release capsules, a prescription medication. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which allows the agency...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,311.86 order is for the supply of 4,564,016,436 units of Methylphenidate LA 40 mg capsules. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that was previously awarded to Amerisourcebergen Drug Corp. The IDC serves as the primary contract vehicle for...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB24FP53Z
    Delivery Order

This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,422.74 firm-fixed-price contract is for the supply of 4,565,215,564 units of the extended-release medication methylphenidate 20mg capsules. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. This delivery order has a performance period ending on July 22, 2024.

Generated 2/27/25, 1:32 PM